Integrative and holistic medical doctors have been using high dose intravenous vitamin C (IVC) to help treat cancer for years. And after countless success stories, the science has finally started to catch up.
Studies are now backing up what they have been seeing with their own eyes.
Lab and animal studies have already proven that vitamin C has the ability to kill cancer cells.1 In experiments the vitamin wipes out cancer cells while leaving healthy ones alone.
Then a University of Iowa study I reported on earlier this year revealed how the vitamin gets the job done.
Just as docs who practice natural medicine have said for years, vitamin C breaks down into hydrogen peroxide in the blood.
Your normal cells have no trouble cleaning up the stuff. Healthy cells contain an enzyme called catalase, which pops the hydrogen peroxide like a balloon leaving only harmless water and oxygen behind.
But cancer cells on the other hand don’t fare so well.
The mutated cells don’t have any catalase of their own. So they essentially drown in the hydrogen peroxide, dying off and causing tumors to shrink.2
Vitamin C may attacks leukemia at a genetic level
Now researchers at the Perlmutter Cancer Center have made yet another breakthrough in our understanding of how vitamin C can help us fight cancer.
When we’re healthy, an enzyme our bodies produce, called TET2, triggers stem cells in our bone marrow to develop. Those stem cells become mature blood cells, which then eventually die.
Except in folks with certain forms of leukemia, the TET2 enzymes don’t work effectively. And as a result, stem cells don’t mature, and die off, as they should.
These faulty cells show up in around…
- 10 percent of people with acute myeloid leukemia
- 30 percent of those with myelodysplastic syndrome
- 50 percent of folks with chronic myelomonocytic leukemia
Plus, to make matters worse, TET2 mutations can pop up in other cancers as well, including lymphomas and solid tumors. In fact, experts say about 42,500 new cases will develop in cancer patients in the U.S. alone every year.
And as those mutated cells multiply, they cause anemia, infections and bleeding.
But this nasty form of blood cancer may have met its match in vitamin C. Because according to the researchers, intravenous vitamin C may have the ability to tell those stubborn mutated stem cells to get with the program.3
And with their new walking papers in hand, the stem cells mature and die normally instead of building up and causing blood cancers.
Intravenous vitamin C suppress human cancer cells
For the experiment, the scientists bred special mice which allowed them to switch the TET2 gene on or off as they saw fit. And just like happens in humans, when they flipped the TET2 genes to the off position the mutated cells started to act abnormally, failing to mature and die.
But, remarkably, high doses of intravenous vitamin C restored the critters TET2 function on the genetic level. Their stem cells started to mature and die normally.
But the benefits didn’t even end there. When the researchers implanted human leukemia cells in mice, the intravenous vitamin C suppressed those cells too.
Of course, we need more research and a clinical trial to see exactly how the IVC effects faulty stem cells in humans. But there’s strong evidence that the IVC therapy that many integrative and holistic docs are already using could help us target cancer in more than one way.
Fighting cancer is an all hand on deck situation. So most doctors use intravenous vitamin C to enhance the effectiveness of other conventional therapies. Because besides its ability to kill cancer cells, studies show the powerful vitamin can put up a fight against fatigue and other cancer treatment side effects.
To learn more about IVC therapy talk with a naturopathic doctor who has experience in treating cancer.
1. “Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer,” Clin Cancer Res. 2010 Jan 15;16(2):509-20. doi: 10.1158/1078-0432.CCR-09-1713
2. “Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy,” Redox Biology, Volume 10, December 2016, Pages 274–284
3. “Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression,” Cell, 2017; DOI: 10.1016/j.cell.2017.07.032
She is an advocate of self-education and is passionate about the power of group knowledge sharing, like the kind found right here on HealthierTalk.com. Alice loves to share her views on holistic and natural healing as well as her, sometimes contentious, thoughts on the profit-driven inner workings of traditional medicine.
Follow Alice and HealthierTalk on Twitter and Facebook.
Latest posts by Alice Jacob (see all)
- 5 different kinds of coughs and what they mean - December 7, 2017
- Drinking coffee could lower risk of cancer and liver disease - December 5, 2017
- 5 healthy Christmas gifts for under $50 bucks - December 4, 2017